PD-L1 tumor expression is associated with poor prognosis and systemic immunosuppression in glioblastoma.
Carolina NoronhaAna Sofia RibeiroRicardo TaipaDina LeitãoFernando SchmittJoaquim ReisCláudia FariaJoana ParedesPublished in: Journal of neuro-oncology (2022)
Taken together, our data points to a putative role for PD-L1 expression in glioblastoma biology, which correlates to poor patient overall survival, as well as with a general systemic inflammatory status and immunosuppression.